Data Mining: Precision Analytical Retrospective Data Correlation
NCT04305093 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144561
Last updated 2023-03-30
Summary
Data from previously analyzed clinical samples tested by Precision Analytical, Inc. will be mined to identify and select samples from patients reporting hormone supplement use. Patient demographics (BMI, for example), different therapies and expected changes in hormone levels will be analyzed and hormone metabolite patterns will be compared. Samples will be deidentified prior to analysis.
Conditions
- Obesity; Endocrine
- Hormone Disturbance
Sponsors & Collaborators
-
Precision Analytical, Inc.
lead INDUSTRY
Principal Investigators
-
Mark Newman, MS · Precision Analytical, Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-15
- Primary Completion
- 2023-03-28
- Completion
- 2023-03-28
Countries
- United States
Study Locations
More Related Trials
-
Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17
NCT06312761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Androgen Deprivation Therapy Study
NCT00743327 ·Status: TERMINATED
-
Evaluating Serum Sex Steroid Hormones
NCT00340756 ·Status: COMPLETED
-
Odense Androgen Study: Study of Androgens, Body Composition, and Muscle Function in Danish Men
NCT00150163 ·Status: UNKNOWN
-
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
NCT03198728 ·Status: COMPLETED ·Phase: PHASE3
-
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
NCT03868059 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
NCT01923870 ·Status: COMPLETED ·Phase: PHASE1
-
Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation
NCT02434562 ·Status: COMPLETED
-
Effects of Testosterone and Fat Utilization
NCT03289559 ·Status: COMPLETED ·Phase: NA
-
Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation
NCT05302726 ·Status: UNKNOWN ·Phase: NA
-
Testosterone Replacement for Male Opioid Agonist Maintained Patients
NCT01873989 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin
NCT01686828 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cross-sectional Study of 1200 Recreational Athletes With Former or Current Use of Androgenic Anabolic Steroids
NCT05178537 ·Status: RECRUITING
-
Survey of Testosterone Levels in Male Cancer Patients
NCT00483418 ·Status: COMPLETED
-
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
NCT01699178 ·Status: COMPLETED ·Phase: PHASE3
-
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism
NCT02102646 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men
NCT01382069 ·Status: COMPLETED ·Phase: PHASE1
-
Odense Androgen Study in the Elderly
NCT00155961 ·Status: COMPLETED
-
Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception
NCT00351819 ·Status: COMPLETED ·Phase: PHASE2
-
Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone
NCT03484260 ·Status: COMPLETED
-
Safety and Efficacy Trial of Testosterone Undecanoate
NCT01765179 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes
NCT03973840 ·Status: COMPLETED ·Phase: PHASE1
-
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
NCT07278362 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Hormone and Information Processing Study
NCT00539305 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Response of Gonadal Steroids and Bone Turnover in Older Men
NCT00114114 ·Status: COMPLETED ·Phase: NA